Here we report the speci®c regulation of gadd45 expression in human melanoma cell lines following UVB radiation. This solar wavelength is likely to be involved in melanoma aetiology. We have previously shown that gadd45 expression is strongly enhanced in a p53-independent manner following UVB irradiation, unlike the other p53 target genes studied. Furthermore, gadd45 is speci®cally activated in melanocytes since its induction in response to UVB, is not observed in other skin cells such as keratinocytes or ®broblasts. To investigate this particular regulation of gadd45, we analysed the UVB-induced response of dierent gadd45 promoter regions. Thus, a minimal promoter region of 50 bp length, responsible for gadd45 activation in melanoma cell lines following UVB irradiation, was determined. In electrophoretic mobility shift assays (EMSAs), we showed that this region (7106/756) of the gadd45 promoter which contains two identical octamers, binds the POU family gene products oct-1 and N-oct3. Given the speci®c expression pattern of Noct3 in melanocyte, we invalidated the expression of this transcription factor in melanoma cells: such an abrogation of N-oct3 protein expression in melanoma cells impeded gadd45 UVB-response. Thus the response of melanocyte to UVB may use an original and previously undescribed pathway. Oncogene (2001) 20, 7375 ± 7385.
Introduction
The development of melanoma is caused both by host and epigenetic factors. Host factors are the skin phototype and susceptibility genes such as CDKN2A which has been shown to be involved in most familial melanomas. The aetiology of this cancer is also in¯uenced by exposition to solar ultraviolet (UV) radiations. These divide into two bands: UVA (315 ± 400 nm) and UVB (280 ± 315 nm). UVA act on DNA through the production of oxidative species (single oxygen). The subsequent guanine oxidation is considered as potentially mutagenic. Experimental studies performed on animals have revealed that UVA can participate in the induction of melanomas (Setlow et al., 1989; Wolf et al., 1994) . Furthermore, epidemiological data have shown that exposition to UVA constitutes a risk factor for melanoma (Wang et al., 2001; Westerdahl et al., 2000) . UVB also trigger an oxidative reaction, but they predominantly produce DNA lesions (cyclobutane pyrimidine dimers and pyrimidine (6 ± 4) pyrimidone photoproducts) which are recognized by the nucleotide excision repair system. Repair errors of the lesions causè UVB signature mutation' (C?T or CC?TT). Recent studies in animal models evidenced that UVB irradiation of human skin grafted in nude mice could induce naevi and melanomas to develop (Atillasoy et al., 1998) . Moreover, it is important to emphasize that UVB is the wavelength that triggers melanogenesis, a skin protective process (Eller et al., 1997) , and that one of the regulation pathways involved requires the activation of DNA repair mechanism (Pedeux et al., 1998) . However, the molecular pathway of UVB action on melanocyte transformation remains unclear.
P53 plays a key part in maintaining cellular integrity, particularly in response to genotoxic stress such as UVB irradiation. To gain further insight into the mechanisms by which UVB may be involved in melanocyte transformation, we investigated the functionality of the p53 protein by studying the expression patterns of some p53 eector genes (p21 WAF1 , mdm2, cyclin G1, gadd45 and bax) following exposition to UVB (and to UVC as reference) in melanoma cell lines. We showed that, as expected, transcription of p53 target genes was enhanced in response to UVC. By contrast, although p53 was activated in response to UVB radiation, none of its target genes was induced but gadd45 (Growth Arrest and DNA Damage-inducible): its increased transcription following UVB was even stronger than following UVC. Moreover, this transcriptional regulation of gadd45 was speci®c of melanocytes since it was not observed in other skin cells such as keratinocytes or ®broblasts (Pedeux et al., submitted) . Gadd45 gene was originally de®ned as a p53 eector gene since its expression has been shown to be dependent on the p53 status in several cell types and since it harbours a p53-responsive element in its third intron. Gadd45 regulation appears complex since it is strictly dependent on the cell type and the genotoxic agents used. In non-melanoma cells, ionizing radiation enhance gadd45 expression in a p53-dependent manner (Kastan et al., 1992; Zhan et al., 1994) . However, Bae et al. (1996) have reported that, in melanoma cells, gadd45 expression is not activated in response to ionizing radiation despite the presence of a wild-type p53. Moreover, Zhan et al. (1993) and Kastan et al. (1992) have demonstrated that, in response to methyl methane sulphonate (MMS) treatment or UVC, gadd45 is transcriptionally induced through a p53-independent pathway. It is now largely admitted that the GADD45 protein is involved in DNA repair since it interacts directly with the PCNA protein Smith et al., 1994) and since it has been shown to modify chromatin accessibility after DNA damage . Moreover, Smith et al. (1996) have demonstrated that GADD45 promotes DNA repair since its abrogation sensitizes RKO cells to UVC radiation. GADD45 also induces cell cycle arrest via p21 WAF1 or by inhibiting cdc2/cyclin B1 kinase activity Yang et al., 2000; Zhan et al., 1999) in order to allow cell repair. In melanoma cells, gadd45 expression is transcriptionally regulated in a p53-independent manner following UVB radiation (Pedeux et al., submitted) . Furthermore, it is speci®cally and strongly expressed in response to UVB in melanocytes whose main physiological function is precisely the production of melanin, considered as the scavenger of free radicals partly produced by UV radiation. In an attempt to investigate this particular gadd45 transcriptional regulation, we performed luciferase assays with dierent gadd45 promoter regions and analysed their promoter activity in response to UVB radiation. These experiments allowed us to determine a 50 bp length region in the gadd45 promoter that contains two identical responsive elements, located at positions 799 and 771 respectively, that are responsible for gadd45 activation following UVB radiation. Furthermore, we identi®ed the POU family gene product N-oct3 as one of the transcription factors required for this speci®c activation. This experimental work permitted to suggest that melanocyte response to UVB may follow an original and previously undescribed pathway.
Results

Specific transcriptional activation of gadd45 in response to UVB radiation in melanoma cells
Our previous studies demonstrated that in human melanoma cells, the expression pattern of several p53 target genes following UV irradiation depends on the UV wavelength used, UVB or UVC. Indeed, all p53 target genes studied are induced following UVC radiation, while, by contrast, only gadd45 gene expression is enhanced in response to UVB radiation, all other p53 target genes tested being either not induced or even repressed. The activation of gadd45 gene reaches a maximum 18 h after UVB or UVC irradiation; hence, this time was chosen for further studies (Pedeux et al., submitted) . p21 WAF1 and gadd45 gene activation pro®les in M4Be melanoma cell line in response to UVB and UVC are presented in Figure 1a . These pro®les are in line with our previously reported results which also demonstrated that gadd45 expression was strongly activated following UVB irradiation in human normal melanocytes (Pedeux et al., submitted) . Thus, the activation of gadd45 following UVB radiation is not distorted by the fact that melanoma cells are actually transformed cells, which validates the experimental model. Furthermore, this gadd45 activation in response to UVB is speci®c to melanocytes since it is not observed in other skin cell types, such as MRC5 ®broblasts or human normal keratinocytes (HNK) (Figure 1b) .
Analysis of gadd45 promoter activity following UVB or UVC radiation
Given that (1) gadd45 expression is induced in response to UVB, (2) this induction is speci®c to melanocytes, among all skin cell types, and (3) UVB is involved in melanoma aetiology, we studied the particular response of the melanocyte by analysing gadd45 promoter activity following UVB irradiation.
To identify the control elements of the gadd45 promoter responsible for its activation by UVB irradiation, dierent gadd45 regions were cloned into a pGL3 vector upstream of a luciferase reporter gene. Because RT ± PCR experiments on melanoma cell lines and human normal melanocytes yielded similar results (Pedeux et al., submitted) , and given the low transfection rates in normal melanocytes, all transfection experiments were performed using melanoma cells, and more especially the WM115 cell line which exhibits a strong activation of gadd45 expression 18 h after UVB irradiation.
Given that in our experimental system the regulation of gadd45 expression is p53-independent (Pedeux et al., submitted), we did not take into account the p53 responsive element (located within the third intron of the gadd45 gene) in our promoter constructs.
The ®rst step of this work was to con®rm the ability of gadd45 promoter to be enhanced by UVB in our model. In this study, the 2.25 kb gadd45 promoter construct (pGadd-2.25 kb) was transfected into WM115 melanoma cells. Transiently expressing cells were then irradiated, or not, by UVB (100 J/m 2 ) or UVC (40 J/m 2 ). This UVB-dose is sucient to induce gadd45 expression, but not too high in order to prevent cellular apoptosis (data not shown). As shown in Figure 2a , the pGadd-2.25 kb reporter vector construct is highly responsive to UVB radiation in WM115 melanoma cell line since the induction is 5.36-fold. However, following UVC radiation pGadd-2.25 kb is activated only 2.19-fold: gadd45 seems to be dierently regulated following UVB and UVC. It is worthy of note that these fold inductions reach values N-oct3 mediated-induction of gadd45 following UVB K Lefort et al comparable to those obtained in RT ± PCR experiments.
To gain insight into the mechanism of gadd45 regulation following UVB irradiation, we performed several site mutations based on the 2.25 kb gadd45 promoter. The sequence analysis of this promoter showed that it contained an AP1-responsive element already described as a UV-responsive element (Devary et al., 1991; Ronai et al., 1994) . This element is situated in the ®rst half of gadd45 promoter, at 71.68 kb from the transcription start site. To investigate the role of AP1 in UVB response, we abrogated this site by introducing a XhoI restriction site using PCR. Abrogating the AP1 responsive element (pGadd-2.25 kb AP1mt ) leads to a decrease in the induction from 5.36-fold to 3.81 following UVB radiation whereas gadd45 induction in response to UVC is maintained (Figure 2a) .
The gadd45 promoter also contains a NF-kBresponsive element that might play a central role in UVB-response. The NF-kB transcription factor has already been described by Bender et al. (1997) as a protein involved in human cell UVB-response. We abrogated this site by replacing it by a XhoI restriction site. As shown in Figure 2a , the luciferase activity of the gadd45 promoter construct lacking the NF-kB site (pGadd-909 bp NF-kBmt ) is maintained, reaching a 4.03-fold following UVB. The decrease was approximately similar following UVC radiation and UVB radiation. Even though AP1 and NF-kB sites can be partially implicated in the response to UV radiation, they are not predominant since they cannot account for the dierences between responses to UVB and UVC.
Therefore, we performed large 5'-deletions in the gadd45 promoter in order to delineate the minimal sequence required for its activation in response to UVB irradiation. As reported in Figure 2b , constructs consisting of 909 bp, 504 bp or 188 bp proximal to the transcription start site are still fully activated by UVB radiation. This activation is similar to that obtained with the pGadd-2.25 kb construct. The two WT1 responsive elements (WT1 REs) located at 7204 and 7198 do not seem to play a pre-eminent role in gadd45 response to UVB radiation though WT1 RE had been shown to be involved in gadd45 activation following UVC in RKO and MCF7 cell lines (Zhan et al., 1998) . However, although the pGadd-188 bp construct displays an induction of 4.42-fold following UVB radiation, the shortest pGadd-57 bp vector does not respond to UVB any more (Figure 2b ). Hence the UVB-responsive site responsible for gadd45 transcriptional enhancement is located between nucleotides 7188 and 757 from the transcription start site. Conversely, the fold inductions remained approximately the same following UVC radiation, indicating that gadd45 transcriptional activation by UVC was not decreased by the 5'-deletions. Identification of a gadd45 promoter responsive element responsible for enhanced gadd45 expression after UVB radiation
In order to determine the responsive site required for inducing gadd45 expression in melanoma cells in response to UVB radiation, we explored the potential responsive elements present in the gadd45 promoter between positions 7188 and 757. The analysis of this (7188/757) promoter region revealed that it contained two octamers capable of binding the POU (Pit-Oct-Unc) family gene products. These sites (5'-ATGCAAAT-3') Figure 2 Transcriptional activity of dierent gadd45 promoter constructs in response to UVB or UVC radiation. WM115 cells were co-transfected for 8 h with 2 mg/ml of dierent pGadd constructs and 50 ng/ml of pRL-CMV (as internal control), then irradiated by UVB (100 J/m 2 ) or UVC (40 J/m 2 ) or untreated as a control and incubated for 18 h. The luciferase assay was performed as described in Materials and methods. Reporter activity which is expressed as fold activation over the basal activity of the promoter in unirradiated cells is normalized to Renilla luciferase activity. The averaged results are of three independent experiments performed in duplicate. Standard deviation of the mean are indicated in brackets or by bars are located respectively at positions 799 and 771, in opposite directions, on each side of a 19 bp sequence harbouring a CCAAT box at position 789.
In order to determine the involvement of these two octamers in gadd45 regulation following UVB radiation, both sites were deleted. Figure 2b shows that the pGadd-106 bp construct which contains the two POUresponsive elements (POU-REs) is highly responsive to UVB radiation with an induction of 3.96-fold. When the POU-RE positioned at 799 and the CCAAT site are absent (construct pGadd-76 bp), the fold induction is clearly diminished, suggesting that these sites are required for gadd45 activation following UVB radiation. Moreover when both POU-REs are deleted (construct pGadd-57 bp), there is a drastic decrease of gadd45 induction in response to UVB radiation (1.50-fold).
Because the short length of these three constructs could eventually limit gadd45 induction, we then generated a 909 bp long construct (pGadd-909 bp D50 bp ) lacking the 50 bp (7106/756) region that harbours the two POU-REs. Results presented in Figure 2c reveal that gadd45 UVB-responsiveness is markedly reduced when this 50 bp region is deleted since fold induction is diminished by more than 400% as compared to the corresponding wild-type construct pGadd-909 bp. By contrast, this deletion does not aect gadd45 UVC-responsiveness.
Characterization of the transcription factors bound to the 50 bp region located between 7106 and 756 in the gadd45 promoter
The POU-responsive element has already been described as a sequence capable of binding several transcription factors belonging to the POU family gene products. We tried to determine which of these transcription factors is eective in the UVB-responsiveness of the gadd45 promoter in melanoma cells. EMSA were carried out with M4Be and WM115 nuclear extracts in the presence of a radiolabelled double-stranded oligonucleotide probe corresponding to the wild-type sequence of gadd45 spanning from 7106 to 756. Competition experiments were performed with unlabelled oligonucleotide corresponding to the wild-type sequence (oct[+]), or oligonucleotide in which both octamers were speci®cally mutated (oct [7] ) or oligonucleotide in which only the 19 bp sequence between the two sites was mutated (19 bp mt). These dierent oligonucleotide probes used in EMSA experiments are represented in Figure 3a . As shown in the EMSA migration pro®le in M4Be cells, two DNA/protein complexes are observed when nuclear extracts are incubated with the oct[+]* wild-type sequence (Figure 3b , lane 4). These DNA bindings are speci®cally restricted to the octamers since they do not appear when both POU-REs are abrogated (oct [7] *, lane 5) and because the same pro®le is observed when the 19 bp region is mutated (19 bp mt*, lane 6). Competition experiments con®rm this binding speci®city since the mutant octamer probe oct [7] does not aect the formation of DNA/protein complexes (lanes 10, 11 and 12), contrary to the wild-type probe oct[+] (lanes 7, 8 and 9) or the 19 bp mutated oligonucleotides (lanes 13, 14 and 15). Similar experiments were carried out with nuclear extracts of UVB-irradiated M4Be cells. As shown in Figure 3b , UVB irradiation does not aect the co-migration pro®le pattern or the DNA binding activity in vitro (lanes 16 ± 27).
For a more precise identi®cation of transcription factors bound to octamer sequences of the gadd45 promoter in melanoma cells, antibodies (Ab) speci®-cally directed against oct-1 or N-oct3 proteins were used in supershift experiments. As shown in Figure 3c , the heaviest complex formed with DNA corresponds to the transcription factor oct-1 (lanes 5 and 7). In this experiment, we used two dierent antibodies directed against oct-1. The rabbit antibody directed against oct-1 (rabbit a-oct1 Ab) probably recognizes peptides that bind to DNA; indeed, it appears to compete with oct-1 and therefore inhibits its binding to the radiolabelled oligonucleotide oct[+]* (lane 5) whereas the unrelated rabbit antibody (rabbit Ab) does not (lane 6). The mouse antibody directed against oct-1 (mouse a-oct1 Ab), however, does not compete with oct-1 but permits its supershift (lane 7). The other complex identi®ed in this experiment is the N-oct3 protein (lane 3). Indeed, addition of an antibody directed against the N-oct3 protein (goat a-oct3 Ab) in the mixture leads to a drastic decrease of the N-oct3/DNA complex (lane 3). Speci®city is demonstrated by the unrelated goat antibody (goat Ab) (lane 4).
Study of gadd45 promoter activity in response to UVB in melanoma cells lacking N-oct3 protein expression
The oct-1 transcription factor has already been shown to be ubiquitously expressed (Sturm et al., 1988) . By contrast, N-oct3 protein expression is restricted to neurectoderm-derived cells (Schreiber et al., 1993; Sturm et al., 1994; Thomson et al., 1993) . Given (1) the speci®city of UVB-response in melanocytes and (2) the restricted N-oct3 expression in melanocyte among skin cell types, we hypothesized an implication of N-oct3 protein in UVB-response of melanoma cells. We therefore established stable transfectants expressing a N-oct3 antisense oligonucleotide in an attempt to abrogate its expression. Due to its high colony forming ability, the M4Be cell line was selected for these experiments. This study was also undertaken using M4Be cells stably transfected with either a N-oct3 sense expression vector or the vector lacking an insert, as controls. N-oct3 expression pattern was examined in each of these clonal cell lines as well as in controls by immunoblotting with an antibody speci®cally directed against the N-oct3 protein (Figure 4a ). We thus isolated two M4Be N-oct3 antisense clonal cell lines that do not express the protein: M4Be-ASO3-6 and M4Be-ASO3-7. As expected, this protein was expressed in control clones stably transfected with the pCI vector alone (M4Be-CMV-5) or the N-oct3 sense expression vector (M4Be-SO3-1) (Figure 4a ). Then, we undertook several luciferase assays on the dierent clonal cell lines, either UVB-irradiated or not, Oncogene N-oct3 mediated-induction of gadd45 following UVB K Lefort et al using the two reporter vectors pGadd-2.25 kb and pGadd-909 bp. The results of these experiments, represented in Figure 4b , show that the fold inductions of gadd45 promoter constructs in control cells M4Be-CMV-5 and M4Be-SO3-1 are similar to those previously obtained in the M4Be parental cell line. Conversely, the reporter vector transcriptional response to UVB is drastically reduced in both clonal cell lines M4Be-ASO3-6 and M4Be-ASO3-7. Indeed the fold inductions obtained in M4Be-ASO3-6 and M4Be-ASO3-7 are respectively 0.85 and 1.12-fold with pGadd-2.25 kb, and 1.45 and 0.79-fold with pGadd-909 pb constructs. This result con®rms the involvement of the N-oct3 transcription factor in the UVB-responsiveness of the gadd45 gene in melanoma cells since the abrogation of its expression leads to an abolition of gadd45 induction following UVB radiation.
Discussion
Most studies related to gadd45 expression in response to DNA damage have used genotoxic agents such as ionizing radiation (Carrier et al., 1994; Chin et al., 1997; Graunke et al., 1999; Papathanasiou et al., 1991; Zhan et al., 1993 Zhan et al., , 1994 , UVC irradiation Takahashi et al., 2001; Zhan et al., 1993 Zhan et al., , 1998 , camptothecin (Takahashi et al., 2001) , or methyl methane sulphonate (Hollander et al., 1993; Zhan et al., 1998) . Until now, studies of gadd45-responsiveness to DNA damage in human melanoma cell lines have used ionizing radiation or UVC irradiation as stressors (Bae et al., 1996; Haapajarvi et al., 1999) . Nevertheless, hardly anything is known about gadd45 regulation in response to UVB radiation in melanoma cells, a cell type that is particularly exposed to this solar wavelength. Sun exposure is a risk factor for melanoma (Gilchrest et al., 1999) . Even if the wavelengths involved in melanoma development are not known precisely, studies have demonstrated that UVB could be at least partially responsible for melanocyte transformation. In this context, we ®rst analysed p53 target gene expression following UVB and UVC (as a reference) in melanoma cell lines (Pedeux et al., submitted) . This study enabled us to show that gadd45 expression is speci®cally and highly enhanced in Whereas UVC activated all the p53 downstream genes tested, UVB radiation did not (except for the gadd45 gene) despite an increased p53 protein level. Furthermore, gadd45 is the only gene to be triggered following irradiation with high UVB doses while all other genes tested are down regulated. We demonstrated that gadd45 activation in response to UVB does not depend on p53 wild-type status in melanoma cells since gadd45 UVB-enhanced expression is also detected in p53-mutated melanoma cells (Pedeux et al., submitted) . We consequently focused our attention on this singular melanocyte-response to UVB. We investigated the pathway involved in UVB response of melanoma cells by analysing the strong UVB-induced activation of gadd45. GADD45 has been shown to be involved in DNA repair mechanisms after DNA damage Hall et al., 1995; Smith et al., 1994 Smith et al., , 1996 . Thus, given its role in the cellular response to genotoxic stress, GADD45 could take a prominent part in melanocytes whose physiological function is the production of melanin pigments that ensure skin protection against solar radiation (Eller et al., 1997) .
In an attempt to elucidate the stimulation of gadd45 expression by UVB in melanoma cells, we searched the gadd45 promoter for UVB-responsive elements that would be responsible for its induction following UVB irradiation. Our ®rst step was to abrogate gadd45 promoter sites which had already been described as being implicated in the response to UV radiation, then we analysed the ability of these dierent constructs to activate luciferase reporter gene. It is known that irradiation UVB or UVC irradiation of mammalian cells causes the activation of AP1 and NF-kB transcription factors (Bender et al., 1997; Devary et al., 1991) . Thus we abrogated these two potential UVresponsive elements in the gadd45 promoter. However, mutation of either of these sites did only moderately decrease gadd45 responsiveness. Therefore, AP1 and NF-kB sites cannot be considered as the main UVB responsive elements in this promoter. Then, we gradually deleted the gadd45 promoter in order to target the UVB responsive element more precisely. Interestingly, we observed that WT1 RE does not interfere with either the UVB or UVC response of gadd45 in this cell type. It is worthy of note that Zhan et al. (1998) have demonstrated that this WT1 RE is involved in gadd45 activation following UVC radiation. However, their study was performed on MCF7 and RKO cell lines, where the activation of gadd45 following UVC radiation has already been shown to be p53-dependent. Hence, even after exposure to the same genotoxic stress, gadd45 activation pathways diers, depending on the cell type. This enforces the observation that gadd45 response is dependent on the cell type.
More interestingly, deletion analyses permitted to delineate a region of 50 bp encompassing nucleotides 7106 to 756, that comprises UVB-RE responsible for the gadd45 strong and speci®c induction in response to UVB radiation in melanoma cells. However, the abrogation of this 50 bp promoter region did not change gadd45 activation levels following UVC, thus ) and incubated for 18 h. Reporter activity which is expressed as fold activation over the basal activity of the promoter in unirradiated cells is normalized to Renilla luciferase activity. The experiments were repeated twice and results shown are data from a representative experiment. Standard deviation of the mean are indicated by bars demonstrating that it does not take any part in the UVC-response of gadd45. These observations are consistent with other studies reporting the localization of DNase I hypersensitive sites in this same region of gadd45 promoter following ionizing radiation (Graunke et al., 1999) and camptothecin treatment (Xiao et al., 2000) . In this context, EMSA performed on this 50 bp region of the gadd45 promoter led us to determine that the responsive elements that mediate gadd45 UVB-induction are the octamer ATGCAAAT since no DNA/protein complex was formed when these two octamer motives were mutated. Moreover, in agreement with Takahashi et al. (2001) , the CCAAT box alone does not seem to be sucient to activate gadd45 expression following UVB since the mutation of the 19 bp (containing the CCAAT box) located between the two octamers does not change the migration pro®le of the DNA/protein complexes. However, Jin et al. (2001) have recently evidenced that mutation of the CCAAT box along with mutation of one of the octamers drastically decreased the gadd45 promoter activity in response to MMS or UVC.
The use of speci®c antibodies in these EMSA experiments indicated that, in melanoma cells, two transcription factors, oct-1 and N-oct3, bind to this cisregulatory site, as already described (Schreiber et al., 1993; Sturm et al., 1991; Thomson et al., 1993) . Whereas the oct-1 protein is ubiquitously expressed (Sturm et al., 1988) , the N-oct3 transcription factor is expressed only in cells derived from the neurectodermal lineage, i.e nervous cells and melanocytes (Schreiber et al., 1993; Sturm et al., 1994; Thomson et al., 1993) . Given the speci®c response of melanocytes to UVB radiation, compared to other skin cell types which do not express the N-oct3 protein, we chose to analyse the potential role of N-oct3 in the regulation of gadd45 following UVB radiation in melanoma cells. We abrogated the N-oct3 factor expression in M4Be melanoma cell line using an antisense RNA expression strategy. It is worthy of note that Thomson et al. (1995) had already succeeded in establishing N-oct3-lacking melanoma cells. We thus used approximately the same antisense sequence in our own experiments. We showed that gadd45 gene expression was not induced following UVB radiation in melanoma cells lacking N-oct3 protein. The present report is the ®rst evidence of an involvement of the N-oct3 protein in this gadd45 regulation in melanoma cells following UVB treatment. Our demonstration that gadd45 UVBresponse is mediated by a melanocyte-speci®c transcription factor brings new insight into the celldependent mechanism of gadd45 regulation. Three recent studies have reported that oct-1 transcription factor is involved in gadd45 gene regulation but the cell lines used in these experiments, MCF7, HCT116 (Jin et al., , 2001 and HeLa (Takahashi et al., 2001) harbour only the oct-1 POU family transcription factor; hence the authors could easily speculate that this factor is the one that binds to the gadd45 octamer sequence. In melanoma cells, the two POU family transcription factors oct-1 and N-oct3 are expressed and our own experiments demonstrate that they both can bind to the ATGCAAAT sequence in vitro.
The N-oct3 protein has been shown to be involved in melanocyte dierentiation and malignant transformation (Thomson et al., 1995) . Although the binding activity of this transcription factor in response to dierentiating (Sturm et al., 1991) and oxidizing agents (Smith et al., 1998) has already been studied, nothing is known about its regulation following exposure to DNA damaging agents, or even less in response to UVB radiation. Our EMSA experiments revealed that N-oct3 is bound to the gadd45 promoter. However, no change in protein level or DNA binding ability was observed in response to UVB. Moreover a kinetic study of N-oct3 and oct-1 activation following UVB or UVC revealed that their protein level remained constant during the time course of the experiments (data not shown). This suggests that, in melanoma cells, these transcription factors are regulated at a post-translational level in response to these stressors. Interestingly, Graunke et al. (1999) have also shown that octamer sites are always occupied whether the cells are treated by ionizing radiation or not. So, they suggested that this genotoxic agent up-regulates gadd45 expression by altering prebound transcription factor interactions without changing protein binding or chromatin structure. Furthermore, the recent work of Takahashi et al. (2001) led them to the same conclusion about oct-1 transcription factor in response to UVC in HeLa cell line, whereas Zhao et al. (2000) could demonstrate that, in another model, oct-1 was post-transcriptionally upregulated early after MMS treatment. Taken together, these observations reinforce the fact that gadd45 is regulated in a strictly tissue-speci®c fashion and that this control requires speci®c transcription factors to allow cell response following DNA damage.
Even if N-oct3 transcription factor is responsible for UVB-induction of gadd45 gene in melanoma cells, we cannot rule out the possibility of other proteins being involved. In this context, Jin et al. (2000) have speculated that BRCA1 protein could interact with the oct-1 factor in their model since they were unable to show that BRCA1 directly binds to the gadd45 promoter. Moreover, Jin et al. (2001) have recently evidenced that, like the oct-1 protein, the NF-YA transcription factor is able to bind to the gadd45 promoter. However, they could not show that oct-1 and NF-YA interact physically, leading us to speculate that this regulation requires post-translational modi®cations (Jin et al., 2001) . A number of studies have already described post-translational modi®cations of the POU family gene products oct-1 and N-oct3. The in vivo phosphorylation of oct-1 and N-oct3 proteins has already been reported elsewhere (Roberts et al., 1991; Rosfjord et al., 1995) . Furthermore, the protein structure of the POU-homeodomain family factors strongly supports the hypothesis of a potential interaction with other proteins. Indeed, several reports have described such an association with the N-oct3 factor. Inamoto et al. (1997) have demonstrated that the POU domains of several oct factors, including N-oct3, are directly bound to MAT1, a factor involved in the CAK (Cdk-Activating Kinase) complex (CDK7, cyclin H, MAT1), which consequently enhances the phosphorylation of POU domains. Furthermore, Noct3 transcriptional activity could also require coactivation by the oct-1 factor since it has been demonstrated that several POU proteins could act through homo-or heterodimerization (Verrijzer et al., 1992; Vigano and Staudt, 1996) . This work is the ®rst description of an original UVBpathway that implicates the neurectodermal lineagespeci®c POU transcription factor N-oct3. Furthermore, we used a model (solar UVB on melanoma cells) very close to physiological conditions which enforces the relevance of our results. So, it is tempting to speculate that, in this particular cell type, N-oct3 could function as a sensor since it mediates UVB-response through the activation of gadd45 gene in a p53 independent manner, which in turn could allow DNA repair.
Further experiments in this model should account for the mechanisms by which UVB mediate gadd45 activation in melanocytes.
Materials and methods
Cell culture and UV irradiation
The human melanoma cell line M4Be was previously established in the laboratory (Jacubovich et al., 1985) . WM115 melanoma cells were obtained from the American Type Culture Collection (Rockville, MD, USA). MRC5 ®broblasts were grown in Dulbecco's Modi®ed Eagle's Medium (DMEM), and melanoma cells were cultured in Mac Coy's 5A Medium, both supplemented with 10% foetal calf serum, 200 units/ml penicillin and 20 mg/ml streptomycin at 378C in a humidi®ed 5% CO 2 incubator. Human normal primary keratinocytes (HNK) were provided by Dr J Franchi (Parfums Christian Dior, France) and maintained in serumfree keratinocyte growth medium (keratinocyte-SFM, Life Technologies, Inc).
UV treatment
After two washes in medium-free PBS 1670% con¯uent cell cultures were irradiated with a Spectrolinker XL 1000 (Spectronics Corporation). The emission peak is 312 nm for UVB and 254 nm for UVC. Depending on the experiments, cells were exposed to UVB (100 J/m 2 or 150 J/m 2 ), or UVC (40 J/m 2 or 50 J/m 2 ), then incubated at 378C in appropriate medium.
RNA extraction and RT ± PCR
Total RNA was extracted by Tri-Reagent according to the manufacturer's protocol (Sigma). After DNase I treatment (Pharmacia), 1 mg of total RNA was reverse-transcribed as previously described (Kallassy et al., 1997) . Ten per cent of RT ± PCR reaction volume was used for a PCR. Sequences of the speci®c primers used in PCR experiments are as follows (forward/reverse): for gapdh: gapdh F 298, 5'-cgagatccctccaaaatcaa-3'/gapdh R 627, 5'-atccacagtcttctgggtgg-3' (330 bp); for p21 WAF1 : p21 F 1103, 5'-gaagaagggtagctggggct-3'/p21 R 1350, 5'-ctctaaggttgggcagggtg-3' (248 bp); for gadd45: gadd45 F 881, 5'-acagaaactgatgccaaggg-3'/gadd45 R 1049, 5'-ttttccttcctgcatggttc-3' (169 bp). PCR was performed in 30 ml containing the template, 2 ml of dNTPs (10 mM), 1.5 nM MgCl 2 , 1 ml of each primer (10 nM), and 1.2 units of Taq polymerase (Perkin Elmer) in 3 ml of 106PCR buer.
To con®rm RNA isolation and homogeneous RT ± PCR, and to standardize the amounts of cDNA in the samples studied, we measured the RNA concentration, then performed an RT ± PCR with gapdh speci®c primers. To detect any contamination by genomic DNA, most of the primers were chosen from two dierent exons. For quantitative RT ± PCR, 1 mCi of [a 33 -P]dATP (Amersham) was added to each sample, then 25-cycle PCRs were performed using the same parameters as above. The quantitative RT ± PCR products were applied to 10% polyacrylamide gels that were subsequently dried, exposed to a phosphor screen then visualized on a phosphorimager (Molecular Dynamics). The relative mRNA expression was quanti®ed with ImageQuant software (Molecular Dynamics) using the volume quanti®ca-tion option, then data were analysed statistically. Each volume was quanti®ed three times. The mean volume value was then adjusted to the gapdh expression with the following formula: mean target gene volume/mean gapdh volume 6100. To compare the eect of treatment to expression in the control, the control was arbitrarily given a 100 value and the relative expressions post UVB and UVC treatments were calculated after the following formula: value adjusted to gapdh/control value adjusted to gapdh6100.
Plasmid constructs
The human gadd45 promoter region was cloned by PCR using human genomic DNA as a template. Primers were derived from the sequence published by Hollander et al. (1993) , available in GenBank (accession No L24498). They were as follows: forward (containing an additional BglII restriction site) 5'-BglII-tgggtggggcactttaggact-3', reverse 5'-BglII-ggagagagcgcggcgtgcg-3'. The PCR product covering nucleotides 72250 to +271 of the gadd45 promoter was then subcloned into the pGL3 Basic vector (Promega) containing the luciferase reporter gene. Additional promoter constructs were generated by PCR using the previous construct as template. For 5'-deletion constructs, upstream primers used were 5'-HindIII-agggcatatcgagag-3' (for construct pGadd-909 bp), 5'-MluI-cttctgaggtaaactttgccc-3' (for construct pGadd-504 bp), 5'-MluI-ccctcggctcgcctcccgc-3' (for construct pGadd-188 bp), 5'-MluI-caggctgatttgcatagccc-3' (for construct pGadd-106 bp), 5'-MluI-ctgcatgcaaatgaggcgg-3' (for construct pGadd-76 bp) and 5'-MluI-aaggtggttggctgagggtt-3' (for construct pGadd-57 bp).
For the pGadd-2.25 kb AP1mt construct, AP1-RE abrogation was carried out by PCR using construct pGadd-2.25 kb as a template, and replacing the 5'-tgactca-3' site located at 71685 bp by an extended XhoI restriction site acgctcgag. For the pGadd-909 bp NF-kBmt construct, NF-kB-responsive element 5'-gggattccc-3', positioned at 7768 bp, was replaced by an extended XhoI restriction site as above. The pGadd-909 bp D50 bp construct was built as explained. The two primer sets used in PCR were as follows: forward, 5'-KpnIaagcttagggcatatcgagag-3' and reverse, 5'-MluI-cagcctgctccagcaatttg-3' for the 7909 bp / 7101 bp part of the gadd45 promoter; forward, 5'-MluI-aaggtggttggctgagggtt-3' and reverse, 5'-BglII-ggagagagcgcggcgtgcg-3' for the 757 bp / +271 bp gadd45 promoter. The 7909 bp / 7101 bp PCR product was cloned in pGL3 basic vector digested by KpnI and MluI, then the 757 bp /+271 bp PCR product was inserted into previous constructs digested by MluI and BglII. All constructs were veri®ed by sequencing.
Transient transfection and luciferase assays
Cells were plated onto 12-well plates at a density of 180 000 cells per well, then grown for 24 h. Cells were transfected with 1 mg of plasmids (0.94 mg of the Fire¯y experimental plasmid based on pGL3 basic vector, and 0.06 mg of the pRL-CMV Renilla internal control plasmid) using the Lipofectin reagent (Life Technologies-BRL) in Optimem medium. After 8 h incubation at 378C in the presence of the DNA/liposome complexes, the transfection medium was replaced by appropriate fresh medium before incubation for an additional 20 h at 378C. Transfected cells were then washed twice in 1 ml of PBS 1X, then lysed directly by addition to each well of 100 ml passive lysis buer 1X from the`dual luciferase reporter assay' kit (Promega). After 20 min at room temperature, aliquots of 20 ml per well of lysate were transferred to a 96-well microplate, then analysed in a Luminoskan Ascent luminometer (Labsystems) with thè dual luciferase reporter assay' kit (Promega) according to the manufacturer's protocol. Results are expressed as Fire¯y activity normalized to the Renilla luciferase activity.
Oligonucleotide synthesis and labelling
The sense / antisense oligonucleotides corresponding to bases 7106 bp through 756 bp of wild-type gadd45 promoter (oct[+]), or in which the two octamers are mutated (oct [7] ) or in which the 19 bp located between the two octamers are mutated (19 bp mt), were synthesized: 5'-caggctgatttgcatagcccaatggccaagctgcatgcaaatgaggcgga-3'/5'-tccgcctcatttgcatgcagcttggccattgggctatgcaaatcagcctg-3' for oct [+] , 5'-caggctgtgactaggtagcccaatggccaagctgctgactagggaggcgga-3'/5'-tccgcctccctagtcatgcagcttggccattgggctcctagtcacagcctg-3' for oct [7] , and 5'-caggctgatttgcattactgatgccgtcgacgttatgcaaatgaggcgga-3'/5'-tccgcctcatttgcataacgtcgacggcatcagtaatgcaaatcagcctg-3' for 19 bp mt. Underlined nucleotides represent the mutated sequence compared to the wild-type sequence. Complementary oligonucleotides were annealed, then 20 pmoles were endlabelled with g 32 -P-ATP using T4 polynucleotide kinase. Labelled probes were separated from incorporated nucleotides using G-25 spin columns (Pharmacia). Incorporation was then evaluated on a b-counter.
Nuclear extract preparation and electrophoretic mobility shift assay (EMSA) Preparation of nuclear extracts from control or UVBirradiated melanoma cells was carried out as previously described (Schreiber et al., 1989) . Brie¯y, cells were harvested by scraping, washed with cold PBS, then resuspended in cold buer A (10 mM HEPES-KOH pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 1 mg/ml AEBSF (Roche), 2 mg/ml aprotinin, 2 mg/ml leupeptin, 2 mg/ml pepstatin and 1 mg/ml okadaõÈ c acid). After a 15 min incubation, cells were lysed by addition of NP-40 10%, then spun down and extracted in cold buer C (20 mM HEPES-KOH pH 7.9, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mg/ml AEBSF (Roche), 2 mg/ml aprotinin, 2 mg/ml leupeptin, 2 mg/ml pepstatin and 1 mg/ml okadaõÈ c acid) on ice for 15 min. Lysates were clari®ed by centrifugation, then protein concentrations were determined by the Bradford method. EMSA were performed with 5 mg of nuclear extract in the binding buer (4 mM HEPES-KOH pH 7.9, 20 mM KCl, 2.5 mM EDTA, 1 mM DTT, 250 mg BSA, 1 mg/ml AEBSF, 1 mg/ml okadaõÈ c acid, 10% glycerol and 3 mg poly [dI-dC] ). In some experiments, 2 mg of antibodies directed against oct-1 (sc-232X or sc-8024X, Santa-Cruz), N-oct3 (sc-6029X, Santa-Cruz) or unrelated one were added to the pre-incubation mixture. In competition experiments, 10-, 50-, and 100-fold molar excesses of unlabelled probes corresponding to wild-type or mutated sequences were added to the binding reaction before addition of labelled probes. After a 15 min incubation on ice, 40 000 c.p.m. of g 32 -P-labelled probe DNA were added to the mixture then the binding reaction was allowed to proceed at room temperature for another 20 min. The mixtures were resolved on a 0.56TBE, 6% acrylamide gel at 170 V for 3 h. Gels were dried and autoradiography was then performed.
Expression vector constructs and stable transfection
The pCI-Neo-oct3 antisense and pCI-Neo-oct3 sense expression vectors were obtained by PCR from the expression vector pBS-N-oct3 containing the N-oct3 coding region, a generous gift of W Schaner (ZuÈ rich). Given that Thomson et al. (1995) had already obtained a speci®c N-oct3 antisense expression vector containing the N-terminal fragment but lacking the POU domain, primers used were as follows: forward, 5'-atggcgaccgcacgt-3' and reverse, 5'-gtggtgcgcgcctgg-3' (both containing an additional EcoRI restriction site in 5'). The PCR product (771 bp) was then subcloned, in the plus direction for the pCI-Neo-oct3-sense and in the negative direction for the pCI-Neo-oct3-antisense, in the pCI-Neo expression vector by insertion at the EcoRI site. All constructs were sequenced.
M4Be melanoma cells were seeded at 2610 5 per 100-mm culture dishes 24 h prior to transfection. Cells were transfected with 10 mg of pCI-Neo-oct3-antisense or pCI-Neo-oct3-sense expression vector, or with control pCI-Neo vector, using the lipofectin reagent (Life Technologies-BRL) according to the manufacturer's instructions. Transfected cells were placed for selection in 400 mg/ml geneticin (G418) 24 h later for 3 weeks. For each transfection, more than 10 G418 resistant colonies were isolated then cultured independently in selection medium prior to veri®cation of N-oct3 protein expression or non-expression.
Immunoblotting
Cells were harvested by scraping, washed with cold PBS then lysed in ice-cold lysis buer (50 mM Tris-HCl pH 7.4, 0.25 M NaCl, 1 mM CaCl 2 , 0,1% Triton X-100, 50 mM NaF, 10 mg/ ml phenylmethyl sulphonyl¯uoride (PMSF), 0.2 mg/ml leupeptin, 0.2 mg/ml aprotinin, 2 mg/ml tosylphenylalanin chloromethylketone and 2 mg/ml soybean trypsin inhibitor). Equal amounts of proteins (100 mg) were loaded in each lane, separated on a 10% SDS polyacrylamide gel, then transferred to a PVDF membrane (Immobilon, Millipore). Transfer of the proteins to the membrane was monitored by Ponceau S (Sigma) staining. Immunodetection of N-oct3 protein was performed using the polyclonal antibody anti-oct3 sc-6029 or anti-oct1 sc-232, or anti-actin sc-1616 (Santa-Cruz). Detection was performed by peroxidase-conjugation using the antigoat secondary antibody P0449 (Dako) and chemiluminescence detection reagent (ECL, Amersham).
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